# Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients

> **NCT02338934** · PHASE4 · UNKNOWN · sponsor: **Penang Hospital, Malaysia** · enrollment: 30 (estimated)

## Conditions studied

- Secondary Hyperparathyroidism

## Interventions

- **DRUG:** Combination Cinacalcet with Vitamin D analogue

## Key facts

- **NCT ID:** NCT02338934
- **Lead sponsor:** Penang Hospital, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338934, "Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02338934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*